Advisory Board on Radiation and Worker Health (ABRWH or the Advisory Board), National Institute for Occupational Safety and Health (NIOSH), 13295-13296 [2019-06602]

Download as PDF Federal Register / Vol. 84, No. 65 / Thursday, April 4, 2019 / Notices professionals and the public about HIV/ AIDS, Viral Hepatitis and other STDs. Matters To Be Considered: The agenda will include discussions on (1) Prevention of Perinatal HIV, Viral Hepatitis, and Congenital Syphilis: Examples from the Field; (2) Ending the HIV Epidemic—Collaborating Across Geographic Boundaries and Responsibilities; (3) Hepatitis C Virus (HCV) Elimination: Institutional Models; (4) Dating Apps and STD/HIV Risk: Opportunities for Promotion, Prevention, Monitoring and Evaluation; and (5) Updates from Workgroups. Agenda items are subject to change as priorities dictate. The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Sherri Berger, Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2019–06607 Filed 4–3–19; 8:45 am] BILLING CODE 4163–19–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Mine Safety and Health Research Advisory Committee (MSHRAC) Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting for the Mine Safety and Health Research Advisory Committee (MSHRAC). This meeting is open to the public, limited only by the space available. The meeting room accommodates approximately 75 people. If you wish to attend in person or by phone, please contact Marie Chovanec by email at MChovanec@ cdc.gov or by phone at 412–386–5302 at least 5 business days in advance of the meeting. DATES: The meeting will be held on May 6, 2019, 8:30 a.m.–4:30 p.m., EDT and on May 7, 2019, 8 a.m.–120 p.m. EDT. ADDRESSES: NIOSH Pittsburgh Campus, Building 140, Room 140MP, 626 Cochrans Mill Road, Pittsburgh, PA 15236, United States. jbell on DSK30RV082PROD with NOTICES SUMMARY: VerDate Sep<11>2014 17:25 Apr 03, 2019 Jkt 247001 FOR FURTHER INFORMATION CONTACT: Jeffrey H. Welsh, Designated Federal Officer, MSHRAC, NIOSH, CDC, 626 Cochrans Mill Road, Pittsburgh, PA 15236, telephone 412–386–4040; email juw5@cdc.gov. SUPPLEMENTARY INFORMATION: Purpose: This committee is charged with providing advice to the Secretary, Department of Health and Human Services; the Director, CDC; and the Director, NIOSH, on priorities in mine safety and health research, including grants and contracts for such research, 30 U.S.C. 812(b)(2), Section 102(b)(2). Matters To Be Considered: The agenda will include discussions on mining safety and health research projects and outcomes, including updates from two MSHRAC Workgroups, the Health Advisory in the Mining Program Workgroup and the Metal Mining Automation and Advanced Technologies Workgroup; industrial minerals sector research priorities; translation of hand-arm vibration to the hearing canal; ground control challenges in Nevada weak rock; respirable dust control technology; EXAMiner hazard recognition training; slips, trips and falls research; health and safety management systems through safety climate; and lithium ion battery research. The meeting will also include updates from the NIOSH Associate Director for Mining, the Spokane Mining Research Division, the Pittsburgh Mining Research Division, the National Personal Protective Technology Laboratory and the Respiratory Health Division. Agenda items are subject to change as priorities dictate. The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Sherri Berger, Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2019–06604 Filed 4–3–19; 8:45 am] BILLING CODE 4163–19–P PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 13295 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Board on Radiation and Worker Health (ABRWH or the Advisory Board), National Institute for Occupational Safety and Health (NIOSH) Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting of the Advisory Board on Radiation and Worker Health (ABRWH). This meeting is open to the public, limited only by the space available. The meeting space accommodates approximately 150 people and the audio conference line has 150 ports for callers. The public is welcome to submit written comments in advance of the meeting, to the contact person below. Written comments received in advance of the meeting will be included in the official record of the meeting. The public is also welcome to listen to the meeting by joining the teleconference (information below). DATES: The meeting will be held on April 17, 2019 from 8:30 a.m. to 6 p.m., EDT. A public comment session will be held on April 17, 2019 at 6 p.m. and conclude at 7 p.m. or following the final call for public comment, whichever comes first. ADDRESSES: Pittsburgh Marriott City Center, 112 Washington Place, Pittsburg, PA 15219; Phone: (412) 471–4000, Fax: (412) 394–1017 and audio conference call via FTS Conferencing. The USA toll-free dial-in number is 1 (866) 659– 0537; the pass code is 9933701. Web conference by Skype: Meeting CONNECTION: https:// webconf.cdc.gov/zab6/yzdq02pl?sl=1. FOR FURTHER INFORMATION CONTACT: Theodore Katz, MPA, Designated Federal Officer, NIOSH, CDC, 1600 Clifton Road NE, Mailstop E–20, Atlanta, Georgia 30329, Telephone (513) 533–6800, Toll Free 1(800) CDC–INFO, Email ocas@cdc.gov. SUPPLEMENTARY INFORMATION: Background: The Advisory Board was established under the Energy Employees Occupational Illness Compensation Program Act of 2000 to advise the President on a variety of policy and technical functions required to implement and effectively manage the new compensation program. Key functions of the Advisory Board include SUMMARY: E:\FR\FM\04APN1.SGM 04APN1 jbell on DSK30RV082PROD with NOTICES 13296 Federal Register / Vol. 84, No. 65 / Thursday, April 4, 2019 / Notices providing advice on the development of probability of causation guidelines which have been promulgated by the Department of Health and Human Services (HHS) as a final rule, advice on methods of dose reconstruction which have also been promulgated by HHS as a final rule, advice on the scientific validity and quality of dose estimation and reconstruction efforts being performed for purposes of the compensation program, and advice on petitions to add classes of workers to the Special Exposure Cohort (SEC). In December 2000, the President delegated responsibility for funding, staffing, and operating the Advisory Board to HHS, which subsequently delegated this authority to the CDC. NIOSH implements this responsibility for CDC. The Advisory Board’s charter was issued on August 3, 2001, renewed at appropriate intervals, rechartered under Executive Order 13811 on February 12, 2018, and will terminate on September 30, 2019. Purpose: This Advisory Board is charged with (a) providing advice to the Secretary, HHS, on the development of guidelines under Executive Order 13179; (b) providing advice to the Secretary, HHS, on the scientific validity and quality of dose reconstruction efforts performed for this program; and (c) upon request by the Secretary, HHS, advising the Secretary on whether there is a class of employees at any Department of Energy facility who were exposed to radiation but for whom it is not feasible to estimate their radiation dose, and on whether there is reasonable likelihood that such radiation doses may have endangered the health of members of this class. Matters To Be Considered: The agenda will include discussions on the following: NIOSH Program Update; Department of Labor Program Update; Department of Energy Program Update; SEC Petitions Update; SEC Petitions for: Sandia National Laboratory (Albuquerque, New Mexico, 1997– 2011), Area IV Santa Susanna Field Laboratory (Ventura County, California, 1991–1993), Superior Steel Company (Carnegie, Pennsylvania), and Idaho National Laboratory (Scoville, Idaho, 1963–1970); and a Board Work Session. Agenda items are subject to change as priorities dictate. The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and VerDate Sep<11>2014 17:25 Apr 03, 2019 Jkt 247001 Prevention and the Agency for Toxic Substances and Disease Registry. Sherri A. Berger, Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2019–06602 Filed 4–3–19; 8:45 am] BILLING CODE 4163–19–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Interagency Committee on Smoking and Health (ICSH); Notice of Charter Renewal Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of charter renewal. AGENCY: This gives notice under the Federal Advisory Committee Act of October 6, 1972, that the Interagency Committee on Smoking and Health, Department of Health and Human Services, has been renewed for a 2-year period through March 20, 2021. FOR FURTHER INFORMATION CONTACT: Simon McNabb, Designated Federal Officer, Interagency Committee on Smoking and Health, Centers for Disease Control and Prevention, Department of Health and Human Services, Patriot’s Plaza, 395 E Street SW, M/S P06, Washington, DC 20201, telephone (202) 245–0550, Email: BOL1@cdc.gov. The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. SUMMARY: Sherri Berger, Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2019–06605 Filed 4–3–19; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2016–N–1593] Agency Information Collection Activities; Proposed Collection; Comment Request; Medical Device Accessories AGENCY: Food and Drug Administration, HHS. PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 ACTION: Notice. The Food and Drug Administration (FDA or Agency) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on information collections regarding medical device accessories requests. DATES: Submit either electronic or written comments on the collection of information by June 3, 2019. ADDRESSES: You may submit comments as follows. Please note that late, untimely filed comments will not be considered. Electronic comments must be submitted on or before June 3, 2019. The https://www.regulations.gov electronic filing system will accept comments until 11:59 p.m. Eastern Time at the end of June 3, 2019. Comments received by mail/hand delivery/courier (for written/paper submissions) will be considered timely if they are postmarked or the delivery service acceptance receipt is on or before that date. SUMMARY: Electronic Submissions Submit electronic comments in the following way: • Federal eRulemaking Portal: https://www.regulations.gov. Follow the instructions for submitting comments. Comments submitted electronically, including attachments, to https:// www.regulations.gov will be posted to the docket unchanged. Because your comment will be made public, you are solely responsible for ensuring that your comment does not include any confidential information that you or a third party may not wish to be posted, such as medical information, your or anyone else’s Social Security number, or confidential business information, such as a manufacturing process. Please note that if you include your name, contact information, or other information that identifies you in the body of your comments, that information will be posted on https://www.regulations.gov. • If you want to submit a comment with confidential information that you do not wish to be made available to the public, submit the comment as a written/paper submission and in the manner detailed (see ‘‘Written/Paper Submissions’’ and ‘‘Instructions’’). E:\FR\FM\04APN1.SGM 04APN1

Agencies

[Federal Register Volume 84, Number 65 (Thursday, April 4, 2019)]
[Notices]
[Pages 13295-13296]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-06602]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Board on Radiation and Worker Health (ABRWH or the 
Advisory Board), National Institute for Occupational Safety and Health 
(NIOSH)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
announces the following meeting of the Advisory Board on Radiation and 
Worker Health (ABRWH). This meeting is open to the public, limited only 
by the space available. The meeting space accommodates approximately 
150 people and the audio conference line has 150 ports for callers. The 
public is welcome to submit written comments in advance of the meeting, 
to the contact person below. Written comments received in advance of 
the meeting will be included in the official record of the meeting. The 
public is also welcome to listen to the meeting by joining the 
teleconference (information below).

DATES: The meeting will be held on April 17, 2019 from 8:30 a.m. to 6 
p.m., EDT. A public comment session will be held on April 17, 2019 at 6 
p.m. and conclude at 7 p.m. or following the final call for public 
comment, whichever comes first.

ADDRESSES: Pittsburgh Marriott City Center, 112 Washington Place, 
Pittsburg, PA 15219; Phone: (412) 471-4000, Fax: (412) 394-1017 and 
audio conference call via FTS Conferencing. The USA toll-free dial-in 
number is 1 (866) 659-0537; the pass code is 9933701. Web conference by 
Skype: Meeting CONNECTION: https://webconf.cdc.gov/zab6/yzdq02pl?sl=1.

FOR FURTHER INFORMATION CONTACT: Theodore Katz, MPA, Designated Federal 
Officer, NIOSH, CDC, 1600 Clifton Road NE, Mailstop E-20, Atlanta, 
Georgia 30329, Telephone (513) 533-6800, Toll Free 1(800) CDC-INFO, 
Email [email protected].

SUPPLEMENTARY INFORMATION: 
    Background: The Advisory Board was established under the Energy 
Employees Occupational Illness Compensation Program Act of 2000 to 
advise the President on a variety of policy and technical functions 
required to implement and effectively manage the new compensation 
program. Key functions of the Advisory Board include

[[Page 13296]]

providing advice on the development of probability of causation 
guidelines which have been promulgated by the Department of Health and 
Human Services (HHS) as a final rule, advice on methods of dose 
reconstruction which have also been promulgated by HHS as a final rule, 
advice on the scientific validity and quality of dose estimation and 
reconstruction efforts being performed for purposes of the compensation 
program, and advice on petitions to add classes of workers to the 
Special Exposure Cohort (SEC). In December 2000, the President 
delegated responsibility for funding, staffing, and operating the 
Advisory Board to HHS, which subsequently delegated this authority to 
the CDC. NIOSH implements this responsibility for CDC.
    The Advisory Board's charter was issued on August 3, 2001, renewed 
at appropriate intervals, rechartered under Executive Order 13811 on 
February 12, 2018, and will terminate on September 30, 2019.
    Purpose: This Advisory Board is charged with (a) providing advice 
to the Secretary, HHS, on the development of guidelines under Executive 
Order 13179; (b) providing advice to the Secretary, HHS, on the 
scientific validity and quality of dose reconstruction efforts 
performed for this program; and (c) upon request by the Secretary, HHS, 
advising the Secretary on whether there is a class of employees at any 
Department of Energy facility who were exposed to radiation but for 
whom it is not feasible to estimate their radiation dose, and on 
whether there is reasonable likelihood that such radiation doses may 
have endangered the health of members of this class.
    Matters To Be Considered: The agenda will include discussions on 
the following: NIOSH Program Update; Department of Labor Program 
Update; Department of Energy Program Update; SEC Petitions Update; SEC 
Petitions for: Sandia National Laboratory (Albuquerque, New Mexico, 
1997-2011), Area IV Santa Susanna Field Laboratory (Ventura County, 
California, 1991-1993), Superior Steel Company (Carnegie, 
Pennsylvania), and Idaho National Laboratory (Scoville, Idaho, 1963-
1970); and a Board Work Session. Agenda items are subject to change as 
priorities dictate.
    The Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Sherri A. Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-06602 Filed 4-3-19; 8:45 am]
 BILLING CODE 4163-19-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.